ArthroCare (ARTC) Tops Q1 View; Guides FY08 EPS Above the Street
More News related to ARTC
- Summary of JANA Partners 13F; New Stakes in AAPL, CROX, RAI, MSFT, MF, FMCN, Ups Stake in CSCO, FCX
- Studies Presented at Spine Arthroplasty Society Annual Meeting Find Plasma Disc Decompression Effective for Contained Disc Herniation
- Patients Treated for Chronic Tendinosis with TOPAZ(R) Highly Satisfied Study Shows
- Susquehanna Financial Downgrades ArthroCare (ARTC) to Negative
- ArthroCare(R) Establishes Direct Sales Representation in Scandinavia
More News related to Earnings
- Apple's (AAPL) International iPhone Rollout 8 Months Ahead of Schedule -Piper Jaffray
- Solarfun Power (SOLF) volume & volatility Elevated into EPS
- Atticus Capital Q1 13F Shows New 8M Share Stake in Visa (V), Firm Also Likes Gold Stocks (AU, NEM, GFI)
- Lampert Shows New Stakes in CIT, KB Home, PHH, SLM; Raises Stake in Home Depot, AutoNation
- Eddie Lampert Shows New 1.4M Share Stake in PHH Corp. (PHH)
ArthroCare Corp. (Nasdaq: ARTC) reports Q1 EPS of $0.34, 2 cents better than the analyst estimate of $0.32. Revenues for the quarter were $91 million, versus the consensus of $89.32 million.
Sees FY08 GAAP EPS of $1.95-$2.00, versus the consensus of $1.93.
ArthroCare Corporation designs, develops, manufactures, and markets medical devices for use in soft-tissue surgery. [BCS]
Related Categories
EarningsGuidance
Stocks Mentioned
+1.60Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
